[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Enterovirus Vaccine Market Research Report 2024(Status and Outlook)

September 2024 | 115 pages | ID: G89C31A53004EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

Hand, foot and mouth disease (HFMD) was first reported in New Zealand in 1957 and occurs mostly in young children, with a peak incidence at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up. Candidate vaccines containing B4 and B5 genogroups are in development elsewhere but have not yet reached the licensing stage. Other vaccines such as recombinant and other forms of subunit vaccines, vectored vaccines, virus-like particle vaccines are in the early stage of development. In addition, the development of vaccines against Coxsackie A16, A6 and A10 is being considered with a view to developing combination/multivalent vaccines

The Global Enterovirus Vaccine Market Size was estimated at USD 344.74 million in 2023 and is projected to reach USD 483.51 million by 2029, exhibiting a CAGR of 5.80% during the forecast period.

This report provides a deep insight into the global Enterovirus Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Enterovirus Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Enterovirus Vaccine market in any manner.

Global Enterovirus Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sinovac Biotech

Medigen Vaccine Biologics

Shenzhen Neptunus

Sinopharm

Adimmune

Intravacc

Shanghai Zerun Biotechnology

Beijing Minhai Biotechnology

Market Segmentation (by Type)

Coxasckievirus A

Coxasckievirus B

Human Enterovirus 71

Others

Market Segmentation (by Application)

Hospital

Research Institute

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Enterovirus Vaccine Market
  • Overview of the regional outlook of the Enterovirus Vaccine Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Enterovirus Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Enterovirus Vaccine
1.2 Key Market Segments
  1.2.1 Enterovirus Vaccine Segment by Type
  1.2.2 Enterovirus Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ENTEROVIRUS VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Enterovirus Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Enterovirus Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ENTEROVIRUS VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Global Enterovirus Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Enterovirus Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Enterovirus Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Enterovirus Vaccine Sales Sites, Area Served, Product Type
3.6 Enterovirus Vaccine Market Competitive Situation and Trends
  3.6.1 Enterovirus Vaccine Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Enterovirus Vaccine Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 ENTEROVIRUS VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Enterovirus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ENTEROVIRUS VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 ENTEROVIRUS VACCINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Enterovirus Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Enterovirus Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Enterovirus Vaccine Price by Type (2019-2024)

7 ENTEROVIRUS VACCINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Enterovirus Vaccine Market Sales by Application (2019-2024)
7.3 Global Enterovirus Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Enterovirus Vaccine Sales Growth Rate by Application (2019-2024)

8 ENTEROVIRUS VACCINE MARKET SEGMENTATION BY REGION

8.1 Global Enterovirus Vaccine Sales by Region
  8.1.1 Global Enterovirus Vaccine Sales by Region
  8.1.2 Global Enterovirus Vaccine Sales Market Share by Region
8.2 North America
  8.2.1 North America Enterovirus Vaccine Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Enterovirus Vaccine Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Enterovirus Vaccine Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Enterovirus Vaccine Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Enterovirus Vaccine Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Sinovac Biotech
  9.1.1 Sinovac Biotech Enterovirus Vaccine Basic Information
  9.1.2 Sinovac Biotech Enterovirus Vaccine Product Overview
  9.1.3 Sinovac Biotech Enterovirus Vaccine Product Market Performance
  9.1.4 Sinovac Biotech Business Overview
  9.1.5 Sinovac Biotech Enterovirus Vaccine SWOT Analysis
  9.1.6 Sinovac Biotech Recent Developments
9.2 Medigen Vaccine Biologics
  9.2.1 Medigen Vaccine Biologics Enterovirus Vaccine Basic Information
  9.2.2 Medigen Vaccine Biologics Enterovirus Vaccine Product Overview
  9.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Product Market Performance
  9.2.4 Medigen Vaccine Biologics Business Overview
  9.2.5 Medigen Vaccine Biologics Enterovirus Vaccine SWOT Analysis
  9.2.6 Medigen Vaccine Biologics Recent Developments
9.3 Shenzhen Neptunus
  9.3.1 Shenzhen Neptunus Enterovirus Vaccine Basic Information
  9.3.2 Shenzhen Neptunus Enterovirus Vaccine Product Overview
  9.3.3 Shenzhen Neptunus Enterovirus Vaccine Product Market Performance
  9.3.4 Shenzhen Neptunus Enterovirus Vaccine SWOT Analysis
  9.3.5 Shenzhen Neptunus Business Overview
  9.3.6 Shenzhen Neptunus Recent Developments
9.4 Sinopharm
  9.4.1 Sinopharm Enterovirus Vaccine Basic Information
  9.4.2 Sinopharm Enterovirus Vaccine Product Overview
  9.4.3 Sinopharm Enterovirus Vaccine Product Market Performance
  9.4.4 Sinopharm Business Overview
  9.4.5 Sinopharm Recent Developments
9.5 Adimmune
  9.5.1 Adimmune Enterovirus Vaccine Basic Information
  9.5.2 Adimmune Enterovirus Vaccine Product Overview
  9.5.3 Adimmune Enterovirus Vaccine Product Market Performance
  9.5.4 Adimmune Business Overview
  9.5.5 Adimmune Recent Developments
9.6 Intravacc
  9.6.1 Intravacc Enterovirus Vaccine Basic Information
  9.6.2 Intravacc Enterovirus Vaccine Product Overview
  9.6.3 Intravacc Enterovirus Vaccine Product Market Performance
  9.6.4 Intravacc Business Overview
  9.6.5 Intravacc Recent Developments
9.7 Shanghai Zerun Biotechnology
  9.7.1 Shanghai Zerun Biotechnology Enterovirus Vaccine Basic Information
  9.7.2 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Overview
  9.7.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Market Performance
  9.7.4 Shanghai Zerun Biotechnology Business Overview
  9.7.5 Shanghai Zerun Biotechnology Recent Developments
9.8 Beijing Minhai Biotechnology
  9.8.1 Beijing Minhai Biotechnology Enterovirus Vaccine Basic Information
  9.8.2 Beijing Minhai Biotechnology Enterovirus Vaccine Product Overview
  9.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Product Market Performance
  9.8.4 Beijing Minhai Biotechnology Business Overview
  9.8.5 Beijing Minhai Biotechnology Recent Developments

10 ENTEROVIRUS VACCINE MARKET FORECAST BY REGION

10.1 Global Enterovirus Vaccine Market Size Forecast
10.2 Global Enterovirus Vaccine Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Enterovirus Vaccine Market Size Forecast by Country
  10.2.3 Asia Pacific Enterovirus Vaccine Market Size Forecast by Region
  10.2.4 South America Enterovirus Vaccine Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Enterovirus Vaccine by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Enterovirus Vaccine Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Enterovirus Vaccine by Type (2025-2030)
  11.1.2 Global Enterovirus Vaccine Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Enterovirus Vaccine by Type (2025-2030)
11.2 Global Enterovirus Vaccine Market Forecast by Application (2025-2030)
  11.2.1 Global Enterovirus Vaccine Sales (K Units) Forecast by Application
  11.2.2 Global Enterovirus Vaccine Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Enterovirus Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Enterovirus Vaccine Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Enterovirus Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Enterovirus Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Enterovirus Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterovirus Vaccine as of 2022)
Table 10. Global Market Enterovirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Enterovirus Vaccine Sales Sites and Area Served
Table 12. Manufacturers Enterovirus Vaccine Product Type
Table 13. Global Enterovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Enterovirus Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Enterovirus Vaccine Market Challenges
Table 22. Global Enterovirus Vaccine Sales by Type (K Units)
Table 23. Global Enterovirus Vaccine Market Size by Type (M USD)
Table 24. Global Enterovirus Vaccine Sales (K Units) by Type (2019-2024)
Table 25. Global Enterovirus Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Enterovirus Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Enterovirus Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Enterovirus Vaccine Price (USD/Unit) by Type (2019-2024)
Table 29. Global Enterovirus Vaccine Sales (K Units) by Application
Table 30. Global Enterovirus Vaccine Market Size by Application
Table 31. Global Enterovirus Vaccine Sales by Application (2019-2024) & (K Units)
Table 32. Global Enterovirus Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Enterovirus Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Enterovirus Vaccine Market Share by Application (2019-2024)
Table 35. Global Enterovirus Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Enterovirus Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Global Enterovirus Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Enterovirus Vaccine Sales by Country (2019-2024) & (K Units)
Table 39. Europe Enterovirus Vaccine Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Enterovirus Vaccine Sales by Region (2019-2024) & (K Units)
Table 41. South America Enterovirus Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Enterovirus Vaccine Sales by Region (2019-2024) & (K Units)
Table 43. Sinovac Biotech Enterovirus Vaccine Basic Information
Table 44. Sinovac Biotech Enterovirus Vaccine Product Overview
Table 45. Sinovac Biotech Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Sinovac Biotech Business Overview
Table 47. Sinovac Biotech Enterovirus Vaccine SWOT Analysis
Table 48. Sinovac Biotech Recent Developments
Table 49. Medigen Vaccine Biologics Enterovirus Vaccine Basic Information
Table 50. Medigen Vaccine Biologics Enterovirus Vaccine Product Overview
Table 51. Medigen Vaccine Biologics Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Medigen Vaccine Biologics Business Overview
Table 53. Medigen Vaccine Biologics Enterovirus Vaccine SWOT Analysis
Table 54. Medigen Vaccine Biologics Recent Developments
Table 55. Shenzhen Neptunus Enterovirus Vaccine Basic Information
Table 56. Shenzhen Neptunus Enterovirus Vaccine Product Overview
Table 57. Shenzhen Neptunus Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Shenzhen Neptunus Enterovirus Vaccine SWOT Analysis
Table 59. Shenzhen Neptunus Business Overview
Table 60. Shenzhen Neptunus Recent Developments
Table 61. Sinopharm Enterovirus Vaccine Basic Information
Table 62. Sinopharm Enterovirus Vaccine Product Overview
Table 63. Sinopharm Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Sinopharm Business Overview
Table 65. Sinopharm Recent Developments
Table 66. Adimmune Enterovirus Vaccine Basic Information
Table 67. Adimmune Enterovirus Vaccine Product Overview
Table 68. Adimmune Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Adimmune Business Overview
Table 70. Adimmune Recent Developments
Table 71. Intravacc Enterovirus Vaccine Basic Information
Table 72. Intravacc Enterovirus Vaccine Product Overview
Table 73. Intravacc Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Intravacc Business Overview
Table 75. Intravacc Recent Developments
Table 76. Shanghai Zerun Biotechnology Enterovirus Vaccine Basic Information
Table 77. Shanghai Zerun Biotechnology Enterovirus Vaccine Product Overview
Table 78. Shanghai Zerun Biotechnology Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Shanghai Zerun Biotechnology Business Overview
Table 80. Shanghai Zerun Biotechnology Recent Developments
Table 81. Beijing Minhai Biotechnology Enterovirus Vaccine Basic Information
Table 82. Beijing Minhai Biotechnology Enterovirus Vaccine Product Overview
Table 83. Beijing Minhai Biotechnology Enterovirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Beijing Minhai Biotechnology Business Overview
Table 85. Beijing Minhai Biotechnology Recent Developments
Table 86. Global Enterovirus Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 87. Global Enterovirus Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Enterovirus Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 89. North America Enterovirus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Enterovirus Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 91. Europe Enterovirus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Enterovirus Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 93. Asia Pacific Enterovirus Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Enterovirus Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 95. South America Enterovirus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Enterovirus Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Enterovirus Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Enterovirus Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 99. Global Enterovirus Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Enterovirus Vaccine Price Forecast by Type (2025-2030) & (USD/Unit)
Table 101. Global Enterovirus Vaccine Sales (K Units) Forecast by Application (2025-2030)
Table 102. Global Enterovirus Vaccine Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Enterovirus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Enterovirus Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Enterovirus Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Enterovirus Vaccine Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Enterovirus Vaccine Market Size by Country (M USD)
Figure 11. Enterovirus Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Enterovirus Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Enterovirus Vaccine Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Enterovirus Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Enterovirus Vaccine Market Share by Type
Figure 18. Sales Market Share of Enterovirus Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Enterovirus Vaccine by Type in 2023
Figure 20. Market Size Share of Enterovirus Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Enterovirus Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Enterovirus Vaccine Market Share by Application
Figure 24. Global Enterovirus Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Enterovirus Vaccine Sales Market Share by Application in 2023
Figure 26. Global Enterovirus Vaccine Market Share by Application (2019-2024)
Figure 27. Global Enterovirus Vaccine Market Share by Application in 2023
Figure 28. Global Enterovirus Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Enterovirus Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Enterovirus Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Enterovirus Vaccine Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Enterovirus Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Enterovirus Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Enterovirus Vaccine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Enterovirus Vaccine Sales Market Share by Region in 2023
Figure 44. China Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Enterovirus Vaccine Sales and Growth Rate (K Units)
Figure 50. South America Enterovirus Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Enterovirus Vaccine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Enterovirus Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Enterovirus Vaccine Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Enterovirus Vaccine Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Enterovirus Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Enterovirus Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Enterovirus Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Enterovirus Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Enterovirus Vaccine Market Share Forecast by Application (2025-2030)


More Publications